ArticleFrontiers in medicine2023

Immune checkpoint inhibitors efficacy across solid cancers and the utility of PD-L1 as a biomarker of response: a systematic review and meta-analysis.

Timothy S Fitzsimmons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.